AccuLine

Acculine Ltd. is a medical technology company specializing in preventing heart attacks. The company's primary focus is the development of CORA, a non-invasive, point-of-care examination designed for the early detection of coronary artery disease. Acculine Ltd. operates from two locations. One is located at 9 Ha’Psagot St. Petah-Tikva, 4951041 Israel, and the other is at 777 Brickell Ave Suite 500, # 1066 Miami, FL 33131 United States. Acculine Ltd. offers CORA, a non-invasive examination for the early detection of coronary artery disease. This examination is a point-of-care solution. The company highlights several advantages of its product, including its non-invasive nature, which means no radiation is involved. The exam is designed to be cost-effective, with no consumables required. It is also designed to be fast, taking only 4 minutes. Acculine Ltd. emphasizes that its product is economical and can potentially save millions of dollars on medical expenses. The company targets the healthcare, technology, and manufacturing industries. Acculine Ltd. is supported by leading medical institutions and investors. Acculine Ltd. lists several competitive advantages. These include 24/7 support and over 15 years of experience. The company's product, CORA, is non-invasive and radiation-free. It is also cost-effective, with no consumables needed, and provides a fast, 4-minute examination. Acculine Ltd. emphasizes the economical benefits of its product, stating it can save millions of dollars on medical expenses. Acculine Ltd. is led by a team of experienced professionals. Moshe Barel, MSc, serves as CEO & Co-Founder. Amit Reches, PhD, is the CTO. Don Crawford, MBA, is the CBO. Prof. Shai Revzen is the CSO & Co-Founder, and Prof. Aharon Frimerman is the CMO & Co-Founder. The company's values include innovation, a client-first approach, scientific rigor, and collaboration with leading medical institutions. Acculine Ltd. can be contacted via phone at +972-3-5284-803 or email at [email protected].